[1]
“Immunomedied Adverse Reactions in patients treated with Immunological Checkpoints Inhibitors in a filantropic Hospital in Salvador ”, RSD, vol. 10, no. 2, p. e58510212928, Feb. 2021, doi: 10.33448/rsd-v10i2.12928.